CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST) where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Lab Expectations listing page

Read More →

Identify New Immuno-Oncology Strategies Faster with Rapid, One-Step T Cell Activation & Expansion Kits

Andrea Tu, PhD Sep 20, 2023

Analyzing TGF-β Signaling in Cells to Spheroids: High-Throughput Methods Tested by Agilent and CST

Spheroids and related three-dimensional (3D) cell models are rapidly gaining popularity among resear...
Alexandra Foley Aug 16, 2023

Got the "NOS"? Fueling Research with New Nitro-Tyrosine Antibody Tools

Since 2000, Cell Signaling Technology (CST) has offered a rigorously tested and well-cited polyclona...

Cancer Immunotherapy Awareness Month: Fueling the Next Scientific Breakthrough

Did you know June is Cancer Immunotherapy Research Awareness Month? This year, we’ll celebrate 10 ye...
Andrea Tu, PhD Jun 21, 2023

Something to YAP About! Progress in Targeting YAP/TAZ-TEAD Signaling in Cancer Research

YAP and its paralog TAZ (WWTR1), often referred to collectively as YAP/TAZ, are transcriptional co-a...
Antony Wood, PhD May 31, 2023

AACR 2023 Recap: Immunotherapy, CAR-T Cell Therapy Research Dominate

Last month marked the annual American Association for Cancer Research (AACR 2023) meeting, which gat...
Alexandra Foley May 10, 2023

IHC-Validated p16 INK4A Antibody: Jump Start Your Senescence Research

Cell cycle regulation is vital to maintain tissue homeostasis and to prevent sustained proliferative...
Alexandra Foley Apr 19, 2023

tRNA Modification by m7G MTase: Understanding its Role in Cancer and Developmental Disorders

Guest blogger Richard I. Gregory, PhD, is a professor at Harvard Medical School and Principal Invest...

World Cancer Day: A Global Call to Action

What is World Cancer Day? Most people will either be directly or indirectly affected by a cancer dia...
Alexandra Foley Feb 6, 2023

The Biopharma Trends to Watch in 2023, According to CST Scientists

Technological innovation leads to a deeper understanding of the natural world and the underlying cau...
Alexandra Foley Jan 18, 2023

Anti-CAR Linker mAbs: First-to-Market CAR Detection Reagents for CAR-T Therapy

CST® anti-CAR linker antibodies won The Innovation Award from CiteAb in 2023. Read on to learn why! ...
Amrik Singh, PhD Nov 8, 2022

Therapeutic Approaches for the Treatment of Multiple Myeloma

Multiple myeloma is a cancer of plasma cells that is treatable, but not curable. In this blog, we re...
Andrea Tu, PhD Jul 2, 2022

Novel Therapeutic Approaches for Diffuse Large B-Cell Lymphoma

Lymphoma is a cancer of the lymphatic system, a principal part of the body’s immune system. Lymphoma...
Andrea Tu, PhD May 11, 2022

Pancreatic Cancer: Targeting Novel Drivers in the Tumor Microenvironment

Pancreatic cancer is devastating and difficult to diagnose early. The organ is located deep inside t...
Andrea Tu, PhD Apr 27, 2022

Melanoma: Aberrant Signaling Pathways and Therapeutic Approaches

There are three major types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melan...
Andrea Tu, PhD Mar 30, 2022

Emerging Therapeutic Approaches for Prostate Cancer

Approximately 1 in 8 men will be diagnosed with prostate cancer, a disease which accounts for the se...
Andrea Tu, PhD Feb 23, 2022

T Cell Basics: What a Disease Researcher Needs to Know

T cells are highly specialized lymphocytes that play a critical role in the cell-mediated arm of the...
Tamar A Nov 11, 2020

Immuno-Oncology: Can T Cells Be Re-trained to Attack Cancer?

The human immune system comprises an array of ingenious cellular components and mechanisms that coll...
Tamar A Jun 3, 2020

      Categories

      CST Newsletter

      Popular Posts

      Related Posts
      landscape-blue-blog-gradient